FAQs
What is the difference between autograft and allograft bone grafts?
Autografts use the patient’s own bone, providing live cells (osteogenic) and no risk of disease transmission, but require a donor site. Allografts come from screened donors, avoid a second surgical site, and are mainly osteoconductive, with a very low infection risk.
Are synthetic bone grafts as effective as natural grafts?
Synthetic grafts (e.g., hydroxyapatite, β‑TCP) act as scaffolds and are safe with no disease‑transfer risk. They lack live cells, so they’re often combined with growth factors to boost healing; success rates can approach natural grafts when properly used.
How long does it take for a bone graft to heal?
Healing time varies: autografts begin integrating in 4‑8 weeks, allografts show visible bone formation in 6‑12 weeks, and synthetics depend on material—β‑TCP may resorb in 3‑6 months, while hydroxyapatite can persist for years.
What are the risks of disease transmission with allografts?
Modern processing reduces the risk to less than 1 in a million. Donor bone is screened, sterilized, and often demineralized, making transmission extremely rare.
Can lifestyle factors like smoking affect bone graft success?
Yes. Smoking narrows blood vessels, lowers oxygen delivery, and impairs bone cell activity, which can delay graft integration and increase failure rates. Quitting before surgery improves outcomes.
